Deutsche Bank’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History

Deutsche Bank’s Portfolio LABP Stock Details LABP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,176	Closed	-$20.9K	–	4017
2022 Q4	$20.9K	Hold	4,176	–	–	﹤0.01%	3764
2022 Q3	$27K	Hold	4,176	–	–	﹤0.01%	3728
2022 Q2	$30K	Buy	4,176 +3,922	+1,544%	+$35.7K	﹤0.01%	3871
2022 Q1	$4K	Sell	254 -30	-11%	-$763	﹤0.01%	4175
2021 Q4	$14K	Buy	284 +15	+6%	+$1.58K	﹤0.01%	4147
2021 Q3	$39K	Sell	269 -116	-30%	-$15.1K	﹤0.01%	4157
2021 Q2	$44K	Sell	385 -13	-3%	-$1.45K	﹤0.01%	4337
2021 Q1	$38K	Buy	+398	New	+$51.9K	﹤0.01%	4298

Other funds holding LABP

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank's LABP Position: Q1 2023 in Review

Deutsche Bank sold out of Landos Biopharma, Inc. Common Stock (LABP) in Q1 2023, closing a stake of 4,176 shares — an estimated $20.9K sold.

Deutsche Bank first reported a position in LABP in Q1 2021 and held it in 8 quarters. The position peaked at $44K in Q2 2021. 20 funds tracked by Wall St. Rank hold LABP as of Q1 2023.

Deutsche Bank reported no remaining Landos Biopharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Deutsche Bank sold 4,176 Landos Biopharma, Inc. Common Stock shares in Q1 2023, an estimated $20.9K.
Deutsche Bank first reported a position in Landos Biopharma, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
Deutsche Bank's Landos Biopharma, Inc. Common Stock position peaked at $44K in Q2 2021.
20 funds tracked by Wall St. Rank held Landos Biopharma, Inc. Common Stock as of Q1 2023.

Based on Deutsche Bank's 13F filing for Q1 2023, filed 15 May 2023.